HomeMedical SpecialtiesMEDICAL SPECIALTIESManaging ovarian cancer risk in women with BRCA1/2 genetic variants

Managing ovarian cancer risk in women with BRCA1/2 genetic variants

Published on

A new review to help physicians manage the risk of ovarian cancer in women who carry the BRCA1/2 gene mutations is published in CMAJ (Canadian Medical Association Journal).

BRCA1 and BRCA2 genetic variants are a clinically important risk factor for the development of ovarian and breast cancer, and women who carry these variants have a lifetime risk of ovarian cancer of 39–44 per cent and 11–17 per cent, respectively.

“Given the substantial lifetime risk and high mortality of ovarian cancer in women with BRCA1/2 variants, risk reduction is a priority,” says Dr. Melissa Walker, a fifth-year resident in obstetrics and gynecology at the University of Toronto, Toronto, Ontario.

The review, which looked at 46 articles published between 2014 and 2019, provides guidance on screening, preventive surgery, contraception and management of menopausal symptoms.

Highlights:

  • Testing – women with a family history of BRCA1/2 should be tested for the variants, as should women with a diagnosis of ovarian cancer but without family history.
  • Screening – there is no effective screening test to detect ovarian cancer accurately. Ultrasonography and blood tests have high levels of false positives, which can cause anxiety and lead to unnecessary surgery, early menopause and other harms.
  • Surgery to reduce risk – as there are no effective screening programs, surgery to remove ovaries and fallopian tubes can reduce the lifetime risk by 80%. Surgery should be performed between ages 35 and 40 years in women with BRCA1 and between 40 and 45 years in women with BRCA2. Other types of surgery, such as fallopian tube removal and hysterectomy, are also discussed.
  • Contraception and fertility – although evidence is controversial, it appears hormonal contraception is safe for this population. Given that decisions around fertility and family planning are complex, early consultation with a fertility specialist is encouraged.
  • Management of menopausal symptoms – the risk of early menopause resulting from removal of ovaries can be managed with hormone replacement therapy to reduce the negative effects of bone loss, heart disease and other conditions. Women who have had breast cancer are at increased risk of recurrence and should be treated with non-hormonal options. Referral to a menopause specialist is recommended.

“Women with these variants have unique and broad medical needs that cross medical specialties and areas of expertise, from surgery to genetics, oncology to nursing, menopause specialists to social work.” says Dr. Walker. “Multidisciplinary management of these women is essential.”

Latest articles

Popular CT Scans Could Account for 5% of All Cancer Cases A Year

Radiation from imaging could lead to lung, breast and other future cancers, with 10-fold...

Breaking Barriers with Mobile Care

In Canada, marginalized populations face many barriers to accessing the health care they need,...

Advancing women’s health research and care

Historically, women have faced barriers in the diagnosis, treatment and care of many health...

It is time the feds make the long-awaited diabetes device fund a reality

It has been almost a year since the federal government announced that it would...

More like this

High blood pressure? Eat more bananas

New mathematical model demonstrates ratio of potassium to sodium intake key to regulating blood...

UHN addressing care gap in women’s heart health

Elana Trainoff didn’t think it was possible to have a heart attack at age...

Transgender and gender diverse people less likely to receive follow-up after a mental health hospitalization

Transgender and gender diverse individuals who were hospitalized for psychiatric care were less likely...

Smart radar device warns of serious heart issues

Waterloo researchers develop “super-sensitive” radar technology that can unobtrusively monitor heartbeats. Dr. George Shaker has...

Canada’s emergency departments are overwhelmed. Can patient redirection help?

Across Canada, emergency departments are facing an unprecedented surge in patient volumes, stretching resources...

Canada’s first pre-hospital blood transfusion trial could be a ‘lifeline’ for trauma patients

Dr. Brodie Nolan’s latest study takes scientific research into the air to bring hospital-quality...